These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22772460)

  • 1. Management of rheumatoid arthritis: the 2012 perspective.
    Yamanaka H; Seto Y; Tanaka E; Furuya T; Nakajima A; Ikari K; Taniguchi A; Momohara S
    Mod Rheumatol; 2013 Jan; 23(1):1-7. PubMed ID: 22772460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of characteristics and therapeutic efficacy in rheumatoid arthritis patients treated by rheumatologists and those treated by orthopedic surgeons under a team medicine approach at the same institute.
    Momohara S; Inoue E; Ikari K; Yano K; Tokita A; Honjo Y; Sakuma Y; Hiroshima R; Iwamoto T; Seto Y; Tanaka E; Taniguchi A; Yamanaka H
    Mod Rheumatol; 2012 Apr; 22(2):209-15. PubMed ID: 21761229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large observational cohort study of rheumatoid arthritis, IORRA: Providing context for today's treatment options.
    Yamanaka H; Tanaka E; Nakajima A; Furuya T; Ikari K; Taniguchi A; Inoue E; Harigai M
    Mod Rheumatol; 2020 Jan; 30(1):1-6. PubMed ID: 31475852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice.
    Yamanaka H; Tohma S
    Mod Rheumatol; 2006; 16(2):75-6. PubMed ID: 16633925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.
    Lenert A; Lenert P
    Clin Rheumatol; 2017 Jan; 36(1):1-8. PubMed ID: 27896522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term drug related remission may encourage drug withdrawal in patients with rheumatoid arthritis.
    Tezcan ME
    Med Hypotheses; 2019 Apr; 125():89. PubMed ID: 30902159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritis.
    Dale J; Porter D
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):443-55. PubMed ID: 20732643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Challenges in clinical trial design in inflammatory arthritis.
    O'Dell JR
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):457-61. PubMed ID: 20732644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis registries in Sweden.
    van Vollenhoven RF; Askling J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S195-200. PubMed ID: 16273807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
    Pope JE; Hong P; Koehler BE
    J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
    Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
    Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in use of immunomodulatory agents--a rheumatology perspective.
    Her M; Kavanaugh A
    Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):363-8. PubMed ID: 25895821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.